Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2024 Filed Aug 1, 2024 18:14 UTC |
Sherwood AlineDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001446472-24-000008 · primary_doc.xml · derivative · entry 1 Sherwood Aline · CIK 0001922380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2024-07-30 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 2,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 18:02 UTC |
MORRIS DOUGLAS PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 3,537 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001446472-24-000005 · primary_doc.xml · derivative · entry 1 MORRIS DOUGLAS P · CIK 0001007382 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,537 Underlying: Common Stock · 3,537 shares Expires 2024-07-30 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth ( 1/4) of the 3,537 shares vesting on the first anniversary of July 30, 2024, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 3,537 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 22:10 UTC |
Aubert PaulDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001446472-24-000007 · primary_doc.xml · derivative · entry 1 Aubert Paul · CIK 0001730350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2024-07-30 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 2,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 22:07 UTC |
Cleaver HeathDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001446472-24-000006 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2024-07-30 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 2,000 shares, based on continuing service to Bio-PathHoldings, Inc. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 21:56 UTC |
Nielsen Peter HenryDirector · President, CEO & CFO
|
GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001446472-24-000004 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-07-30 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of July 30, 2024, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| May 02, 2023 Filed May 4, 2023 17:49 UTC |
Sherwood AlineDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001446472-23-000012 · primary_doc.xml · derivative · entry 1 Sherwood Aline · CIK 0001922380 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-05-02 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| May 02, 2023 Filed May 4, 2023 17:41 UTC |
MORRIS DOUGLAS PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 13,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001446472-23-000011 · primary_doc.xml · derivative · entry 1 MORRIS DOUGLAS P · CIK 0001007382 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2033-05-02 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 13,000 shares vesting on the first anniversary of May 2, 2023, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 13,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:24 UTC |
Cleaver HeathDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001446472-23-000014 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-05-02 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| May 02, 2023 Filed May 4, 2023 22:00 UTC |
Aubert PaulDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001446472-23-000013 · primary_doc.xml · derivative · entry 1 Aubert Paul · CIK 0001730350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2033-05-02 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| May 02, 2023 Filed May 4, 2023 21:20 UTC |
Nielsen Peter HenryDirector · President, CEO & CFO
|
GrantCommon Stock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001446472-23-000010 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2033-05-02 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 105,000 shares vesting on the first anniversary of May 2, 2023, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 105,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 31, 2022 Filed Apr 8, 2022 17:42 UTC |
Sherwood AlineDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.84 | $0.00 |
DisclosureSEC source: 0001922380-22-000002 · primary_doc.xml · derivative · entry 1 Sherwood Aline · CIK 0001922380 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-03-31 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 18:28 UTC |
MORRIS DOUGLAS PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001007382-22-000001 · primary_doc.xml · derivative · entry 1 MORRIS DOUGLAS P · CIK 0001007382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2032-03-28 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 11,000 shares vesting on the first anniversary of March 28, 2022, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 11,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 21:42 UTC |
Cleaver HeathDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001599765-22-000001 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-03-28 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 21:21 UTC |
Aubert PaulDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001730350-22-000001 · primary_doc.xml · derivative · entry 1 Aubert Paul · CIK 0001730350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-03-28 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 20:56 UTC |
Nielsen Peter HenryDirector · President, CEO & CFO
|
GrantCommon Stock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001444954-22-000001 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2032-03-23 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 90,000 shares vesting on the first anniversary of March 23, 2022, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 90,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 31, 2021 Filed Mar 31, 2021 19:49 UTC |
MORRIS DOUGLAS PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 13,000 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001007382-21-000001 · primary_doc.xml · derivative · entry 1 MORRIS DOUGLAS P · CIK 0001007382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2031-03-31 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 13,000 shares vesting on the first anniversary of March 31, 2021, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 13,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 31, 2021 Filed Mar 31, 2021 23:59 UTC |
Cleaver HeathDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001599765-21-000001 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-03-31 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 00:20 UTC |
Molsbergen Tamaro MartinaDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001791926-21-000001 · primary_doc.xml · derivative · entry 1 Molsbergen Tamaro Martina · CIK 0001791926 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-03-31 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 00:08 UTC |
Aubert PaulDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001730350-21-000001 · primary_doc.xml · derivative · entry 1 Aubert Paul · CIK 0001730350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-03-31 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 31, 2021 Filed Mar 31, 2021 23:33 UTC |
Nielsen Peter HenryDirector · President, CEO & CFO
|
GrantCommon Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001444954-21-000001 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-03-31 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 100,000 shares vesting on the first anniversary of March 31, 2021, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 100,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 22:28 UTC |
Nielsen Peter HenryDirector · President, CEO & CFO
|
GrantCommon Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $5.21 | $0.00 |
DisclosureSEC source: 0001444954-20-000005 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 85,000 shares vesting on the first anniversary of June 16, 2020, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 85,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 17:19 UTC |
MORRIS DOUGLAS PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.07 | $0.00 |
DisclosureSEC source: 0001444954-20-000004 · primary_doc.xml · derivative · entry 1 MORRIS DOUGLAS P · CIK 0001007382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-03-27 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 10,000 shares vesting on the first anniversary of March 27, 2020, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 20:57 UTC |
Cleaver HeathDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.07 | $0.00 |
DisclosureSEC source: 0001444954-20-000003 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-03-27 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 20:38 UTC |
Aubert PaulDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.07 | $0.00 |
DisclosureSEC source: 0001444954-20-000002 · primary_doc.xml · derivative · entry 1 Aubert Paul · CIK 0001730350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-03-27 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 20:25 UTC |
Molsbergen Tamaro MartinaDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.07 | $0.00 |
DisclosureSEC source: 0001791926-20-000001 · primary_doc.xml · derivative · entry 1 Molsbergen Tamaro Martina · CIK 0001791926 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-03-27 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 10,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 21:24 UTC |
Nielsen Peter HenryDirector · President, CEO & CFO
|
GrantCommon Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001444954-20-000001 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-03-18 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 15,000 shares vesting on the first anniversary of March 18, 2020, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 15,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:06 UTC |
MORRIS DOUGLAS PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001007382-19-000002 · primary_doc.xml · derivative · entry 1 MORRIS DOUGLAS P · CIK 0001007382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 1,000 shares vesting on the first anniversary of March 28, 2019, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 1,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 20:49 UTC |
COLONNESE MARK PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001007382-19-000005 · primary_doc.xml · derivative · entry 1 COLONNESE MARK P · CIK 0001040766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 1,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 28, 2019 Filed Apr 2, 2019 00:38 UTC |
Aubert PaulDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001007382-19-000004 · primary_doc.xml · derivative · entry 1 Aubert Paul · CIK 0001730350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 1,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 28, 2019 Filed Apr 2, 2019 00:28 UTC |
Nielsen Peter HenryDirector · President, CEO & CFO
|
GrantCommon Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001007382-19-000003 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 15,000 shares vesting on the first anniversary of March 28, 2019, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 15,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 28, 2019 Filed Apr 1, 2019 23:26 UTC |
Cleaver HeathDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001599765-19-000003 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: This option vests over a one-year period, with the shares vesting in equal monthly increments equal to one-twelfth (1/12) of the 1,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 23:15 UTC |
ARMISTICE CAPITAL, LLC10% owner
Armistice Capital Master Fund Ltd.10% owner
Boyd Steven10% owner
|
SaleCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-19-000549 · ownership.xml · nonDerivative · entry 3 ARMISTICE CAPITAL, LLC · CIK 0001601086 · 10% owner Armistice Capital Master Fund Ltd. · CIK 0001633584 · 10% owner Boyd Steven · CIK 0001706140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 129,298 F2 · ownership.nature: The reported securities are directly owned by the Master Fund, and may be deemed to be indirectly beneficially owned by Armistice Capital, LLC ("Armistice Capital"), as the investment manager of the Master Fund. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital. Armistice Capital and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 23:15 UTC |
ARMISTICE CAPITAL, LLC10% owner
Armistice Capital Master Fund Ltd.10% owner
Boyd Steven10% owner
|
SaleCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-19-000549 · ownership.xml · nonDerivative · entry 2 ARMISTICE CAPITAL, LLC · CIK 0001601086 · 10% owner Armistice Capital Master Fund Ltd. · CIK 0001633584 · 10% owner Boyd Steven · CIK 0001706140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 129,298 F2 · ownership.nature: The reported securities are directly owned by the Master Fund, and may be deemed to be indirectly beneficially owned by Armistice Capital, LLC ("Armistice Capital"), as the investment manager of the Master Fund. The reported securities may also be deemed to be indirectly beneficially owned by Steven Boyd as Managing Member of Armistice Capital. Armistice Capital and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 23:15 UTC |
ARMISTICE CAPITAL, LLC10% owner
Armistice Capital Master Fund Ltd.10% owner
Boyd Steven10% owner
|
SaleCommon Stock | 64,457 | $2.66 | $171,642.55 |
DisclosureSEC source: 0000919574-19-000549 · ownership.xml · nonDerivative · entry 1 ARMISTICE CAPITAL, LLC · CIK 0001601086 · 10% owner Armistice Capital Master Fund Ltd. · CIK 0001633584 · 10% owner Boyd Steven · CIK 0001706140 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,298 F1 · ownership.direct: The reported securities are directly owned by Armistice Capital Master Fund Ltd., a Cayman Islands corporation (the "Master Fund"). Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 17:06 UTC |
MORRIS DOUGLAS PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001599765-18-000002 · primary_doc.xml · derivative · entry 1 MORRIS DOUGLAS P · CIK 0001007382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-04-17 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 20,000 shares vesting on the first anniversary of April 17, 2018 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 20,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 17:18 UTC |
COLONNESE MARK PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001599765-18-000003 · primary_doc.xml · derivative · entry 1 COLONNESE MARK P · CIK 0001040766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-04-17 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 20,000 shares vesting on the first anniversary of April 17, 2018 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 20,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 21:25 UTC |
Aubert PaulDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001599765-18-000004 · primary_doc.xml · derivative · entry 1 Aubert Paul · CIK 0001730350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2028-04-17 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 17,500 shares vesting on the first anniversary of April 17, 2018 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 17,500 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 20:53 UTC |
Cleaver HeathDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001599765-18-000001 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-04-17 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 20,000 shares vesting on the first anniversary of April 17, 2018 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 20,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| April 11, 2018 Filed Apr 13, 2018 21:01 UTC |
Nielsen Peter HenryDirector · President, CEO & CFO
|
GrantCommon Stock Option (right to buy) · Derivative | 130,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001444954-18-000001 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2028-04-11 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 130,000 shares vesting on the first anniversary of April 11, 2018 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 130,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 22:39 UTC |
Aubert PaulDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0001730350-18-000002 · primary_doc.xml · derivative · entry 1 Aubert Paul · CIK 0001730350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of February 1, 2018 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| July 13, 2017 Filed Jul 17, 2017 16:22 UTC |
COLONNESE MARK PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.38 | $0.00 |
DisclosureSEC source: 0001603963-17-000003 · primary_doc.xml · derivative · entry 1 COLONNESE MARK P · CIK 0001040766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-07-13 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of July 13, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| May 01, 2017 Filed May 2, 2017 20:15 UTC |
Mueller Ulrich W.COO & Secretary
|
GrantCommon Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $0.67 | $0.00 |
DisclosureSEC source: 0001603963-17-000001 · primary_doc.xml · derivative · entry 1 Mueller Ulrich W. · CIK 0001603963 · COO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-05-01 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 125,000 shares vesting on the first anniversary of May 1, 2017, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 125,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 16:10 UTC |
MORRIS DOUGLAS PDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001007382-17-000001 · primary_doc.xml · derivative · entry 3 MORRIS DOUGLAS P · CIK 0001007382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-03-23 F2 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of March 23, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 20:51 UTC |
Cleaver HeathDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001007382-17-000004 · primary_doc.xml · derivative · entry 1 Cleaver Heath · CIK 0001599765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-03-23 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of March 23, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 21:02 UTC |
Garrison Michael J.Director
|
GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001007382-17-000005 · primary_doc.xml · derivative · entry 4 Garrison Michael J. · CIK 0001559390 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-03-23 F2 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of March 23, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 20:38 UTC |
Mueller Ulrich W.COO & Secretary
|
GrantCommon Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001007382-17-000003 · primary_doc.xml · derivative · entry 1 Mueller Ulrich W. · CIK 0001603963 · COO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-03-23 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 200,000 shares vesting on the first anniversary of March 23, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 200,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 20:21 UTC |
SING AMYDirector
|
GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001007382-17-000002 · primary_doc.xml · derivative · entry 1 SING AMY · CIK 0001202789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-03-23 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of March 23, 2017 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.